Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy
© 2020, The Author(s). There are no licensed therapeutics or vaccines available against Zika virus (ZIKV) to counteract its potential for congenital disease. Antibody-based countermeasures targeting the ZIKV envelope protein have been hampered by concerns for cross-reactive responses that induce ant...
Saved in:
Main Authors: | Alex W. Wessel, Nurgun Kose, Robin G. Bombardi, Vicky Roy, Warangkana Chantima, Juthathip Mongkolsapaya, Melissa A. Edeling, Christopher A. Nelson, Irene Bosch, Galit Alter, Gavin R. Screaton, David H. Fremont, James E. Crowe, Michael S. Diamond |
---|---|
Other Authors: | Vanderbilt University Medical Center |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/59851 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
The immunology of Zika Virus
by: Gavin Screaton, et al.
Published: (2019) -
Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection
by: Estefania Fernandez, et al.
Published: (2018) -
Dengue and Zika Virus Cross-Reactive Human Monoclonal Antibodies Protect against Spondweni Virus Infection and Pathogenesis in Mice
by: Vanessa Salazar, et al.
Published: (2020) -
The acquired immune response in dengue virus infection
by: Gavin Screaton, et al.
Published: (2018) -
Which dengue vaccine approach is the most promising, and should we be concerned about enhanced disease after vaccination?: The challenges of a dengue vaccine
by: Gavin Screaton, et al.
Published: (2019)